Hansa’s preliminary Q1 result suggests that Idefirix records European product sales of SEK 48 (43m i...
Nettoomsättningen uppgick till 62,0 MSEK (59,0) i det tredje kvartalet (november-januari) i Purefuns...
- Confirms a long-term obesity and diabetes device contract - No material impact next 2Y, ~SEK 700m ...
Duell publishes its Q2/24 results on Thursday 4th of April.
Redeye is favorable to the communicated new order by Waystream just after the market closed on Thurs...
Redeye retains its positive view on Hexatronic and keeps its outlook for Hexatronic regarding Q1 and...
Redeye comments on Ngenic’s intention to divest its subsidiary Ngenic Sweden AB to Nordic Propeye fo...
The Human Research Ethics Committee (HREC) has provided the green light to commence enrolment for Me...
Redeye comments on Thunderful Group’s divestment of Headup.
Pricer has updated its financial targets Sales +15% p.
Minor estimate revisions Expect primarily volume-driven growth FVR of SEK 20-35 reiterated What to ...
Den virtuella satellitsnätsoperatören Wyld Networks ("Wyld") har påbörjat leverans av produkter unde...
Redeye trims its forecasts for Q1 2024 slightly while retaining its Base Case and comments on the FT...
In Q4-23, Movinn A/S (“Movinn” or the “Company”) continued to be affected by high vacancy rates, whi...
Windon Energy Group meddelade den 27 mars år 2024 att bolaget har ingått ett partnerskap i Norge med...
2024 förväntas bli ett övergångsår men de långsiktiga tillväxtutsikterna framstår som goda.
Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is goin...
Last week, Cibus issued green notes of EUR 80m and SEK 700m and launched a tender offer for bonds ma...
Bolaget presenterar vägen framåt I samband med bolagets kapitalmarknadsdag presenterades nya finansi...
Redeye comments on Freemelt’s new order from Saab Dynamics.
